HAVCR2 and B-cell chronic lymphocytic leukemia: Fraietta et al. reported that cells simultaneously expressing PD-1 and Tim-3 or Lag-3 were enriched in infusion products of partially and non-responding patients with chronic lymphocytic leukemia in comparison to patients achieving complete remission [34].